NCT00001092|Completed
The Biology of HIV Transmission
The Determinants of the Biology of HIV Transmission to Determine the Immunologic and Virologic Characteristics of Those Who May Have Transmitted HIV to Another Individual
Loading search results
The Determinants of the Biology of HIV Transmission to Determine the Immunologic and Virologic Characteristics of Those Who May Have Transmitted HIV to Another Individual
Sponsor study identifier
Secondary identifiers
observational
20
1 country
3
Study Start
October 1999
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2008
Actual (reported)Study Completion
October 2008
Actual (reported)The purpose of this study is to look at the amount of HIV in the blood, genital fluid, and saliva of the partners of patients with early HIV infection. This study will also look at the strength of the immune systems of patients with early HIV infection. Because HIV multiplies very quickly in the early stages of infection, patients with early HIV infection may be more likely to transmit HIV to their partners. The amount of HIV in blood, genital fluid, and saliva may determine the risk for transmission.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 1999
Date type not reportedThis date has not been verified as actual or estimated.
November 2, 1999
Actual (reported)August 31, 2001
Actual (reported)October 2008
Actual (reported)October 2008
Actual (reported)HIV-infected adults with recent seroconversion
Contact the study team to confirm eligibility.
Cedars Sinai Med Ctr
Los Angeles, California, 90048, United States
UCSD
San Diego, California, 92103, United States
San Francisco Gen Hosp / UCSF AIDS Program
San Francisco, California, 94110, United States
Blood, genital fluids, and saliva collection
James Kahn
Margaret Chesney
Rick Hecht
Susan Little
Eric Daar
First Submitted
November 2, 1999
First Posted
August 31, 2001
Study Start
October 1999
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2008
Actual (reported)Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV
Jay Levy
Robert Grant
Study Completion
October 2008
Actual (reported)Last Updated
October 22, 2015
Record last verified: 2015-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: